Answers are grounded in this paper and cite their sources.
The synthesis, spectroscopic characteristics and in vitro cellular uptake properties of a new class of therapeutic window photosensitiser, namely the BF2 chelates of 3,5-diaryl-1H-pyrrol-2-yl-3,5-diarylpyrrol-2-ylidene amines (tetra-arylazadipyrromethenes), are described with the aim of developing a novel class of photodynamic therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Killoran et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: